| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f87c776a3d31eb994d3c9629e87922b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ff15fae4c8dc6e020fa7a8741e6eea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ddd4d1d0ebc8a7d2c8e7d214d08cf3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0812 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
1995-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7be7fc4698858fafe79b6260c1cf8eb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9beac9a71eb7baf145efa10273867d31 |
| publicationDate |
1995-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9531462-A1 |
| titleOfInvention |
Hymenialdisine and derivative thereof, process for producing intermediate for synthesizing the same, and said intermediate |
| abstract |
Hymenialdisine represented by general formula (I) and a derivative thereof, and a process for producing the same, wherein X1 represents halogen or hydrogen. These compounds have a protein kinase C inhibitory effect and are expected as a remedy for diseases wherein protein kinase C activation is thought to participate. |
| priorityDate |
1994-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |